The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.895
High: 0.895
Low: 0.895
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Seventh Mandatory Redemption

25 Mar 2020 07:00

RNS Number : 4189H
JPEL Private Equity Limited
25 March 2020
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

JPEL ANNOUNCES SEVENTH MANDATORY REDEMPTION

 

 

· REDEMPTION DATE 31 MARCH 2020

 

· JPEL WILL RETURN $40 MILLION TO SHAREHOLDERS

 

· REPRESENTS 14.8% OF US$ EQUITY SHAREHOLDER NET ASSET VALUE AT 31 DECEMBER 2019

 

* * *

 

GUERNSEY, 25 MARCH 2020

 

 

The Board of Directors of JPEL Private Equity Limited ("JPEL" or the "Company") is pleased to announce JPEL's seventh capital distribution in respect of the Company's US$ Equity Share class ("Mandatory Redemption").

 

JPEL has benefitted from a strong level of realisations from its underlying portfolio and the Company has resolved to return a total of $40 million to JPEL US$ Equity Shareholders.

 

The $40 million capital return (the equivalent of approximately 22.35 million US$ Equity Shares, or 14.8% of US$ Equity Shareholder NAV) will be by way of a pro rata compulsory redemption of US$ Equity Shares at a price equal to the prevailing NAV per US$ Equity Share of $1.79 as at 31 December 2019 (being the most recent NAV per US$ Equity Share available as of the date of this announcement) for US$ Equity Shareholders on the register of members as at close of business on 31 March 2020 ("Record Date"). Unless circumstances require otherwise, this NAV will form the NAV per US$ Equity Share as of the date of redemption.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 9 April 2020. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or around 9 April 2020.

 

The Company currently has 151,447,719 US$ Equity Shares in issue. All of the US$ Equity Shares redeemed on the redemption date will be cancelled and any fractions of shares will be rounded down to the nearest whole share.

 

The US$ Equity Shares will be disabled in CREST on the Record Date and the existing ISIN number GG00BKTRF395 (the "Old ISIN") will expire. A new ISIN number GG00BMDQPC56 (the "New ISIN") in respect of the remaining US$ Equity Shares which have not been redeemed will be enabled and available for transactions on 1 April 2020. For the period up to and including the Record date, US$ Equity Shares will be traded under the Old ISIN and as such, a purchaser of such shares may have a market claim for the redemption proceeds following the activation of the New ISIN. CREST will automatically transfer any open transactions as at the redemption date to the New ISIN.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $339.2 million to US$ Equity Shareholders, or approximately 71% of the Company's 31 October 2016 NAV, the prevailing NAV at the time of the Company's first mandatory redemption.

 

DIRECTOR'S INTERESTS

 

As of 23 March 2020, Sean Hurst, Christopher Spencer and Tony Dalwood, Directors of the Company, owned 11,169, 13,475 and 57,244 US$ Equity Shares, respectively. As a result of the Mandatory Redemption described above, Sean Hurst, Christopher Spencer and Tony Dalwood are expected, immediately following the redemption date, to hold approximately 9,521, 11,487 and 48,798 US$ Equity Shares, respectively.

 

 

 

* * *

 

 

 

 

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CASMZGZFKDNGGZM
Date   Source Headline
23rd Oct 20145:12 pmRNSTransaction in Own Shares
15th Oct 20147:00 amRNSNet Asset Value(s)
3rd Oct 20147:00 amRNSAnnual Financial Report
30th Sep 20145:16 pmRNSHolding(s) in Company
29th Sep 20145:35 pmRNSHolding(s) in Company
19th Sep 20145:03 pmRNSTransaction in Own Shares
18th Sep 20146:18 pmRNSHolding(s) in Company
18th Sep 20147:00 amRNSNet Asset Value(s)
15th Sep 20143:43 pmRNSHolding(s) in Company
12th Sep 20144:59 pmRNSHolding(s) in Company
11th Sep 20144:23 pmRNSHolding(s) in Company
10th Sep 20145:39 pmRNSHolding(s) in Company
22nd Aug 20144:00 pmRNSAdmission of Shares
7th Aug 20147:00 amRNSNet Asset Value(s) & Quarter End Review June 2014
4th Aug 20147:00 amRNSDisposal
16th Jul 201410:12 amRNSDirector Declaration
1st Jul 20144:51 pmRNSHolding(s) in Company
1st Jul 20147:00 amRNSNet Asset Value(s)
20th Jun 20147:00 amRNSExtension of Existing Credit Facility
19th Jun 20144:03 pmRNSHolding(s) in Company
9th Jun 20147:00 amRNSNet Asset Value(s)
22nd May 20147:00 amRNSPartial Exit
13th May 20146:10 pmRNSNet Asset Value(s)
2nd May 201410:02 amRNSResult of AGM
30th Apr 20145:03 pmRNSSignificant Investment Progress Announcement
4th Apr 201411:30 amRNSAGM Circular
1st Apr 20145:56 pmRNSNet Asset Value(s) & Monthly Report February 2014
14th Mar 20143:33 pmRNSNet Asset Value(s) and Monthly Report January 2014
26th Feb 20144:11 pmRNSHalf Yearly Report
11th Feb 20145:40 pmRNSMonthly Report - December 2013
11th Feb 20145:31 pmRNSNet Asset Value(s)
6th Feb 20145:09 pmRNSAppointment of Joint Corporate Broker
17th Jan 20145:47 pmRNSHolding(s) in Company
17th Jan 20144:39 pmRNSHolding(s) in Company
16th Jan 20146:06 pmRNSHolding(s) in Company
16th Jan 20146:05 pmRNSHolding(s) in Company
16th Jan 20145:56 pmRNSHolding(s) in Company
15th Jan 20147:00 amRNSStrategic Update
30th Dec 20135:11 pmRNSMonthly Report - November 2013
30th Dec 20135:08 pmRNSNet Asset Value(s)
5th Dec 201312:10 pmRNSMonthly Report - October 2013
5th Dec 201311:58 amRNSNet Asset Value(s)
26th Nov 20133:02 pmRNSHolding(s) in Company
25th Nov 20135:03 pmRNSHolding(s) in Company
20th Nov 20135:17 pmRNSHolding(s) in Company
20th Nov 20135:14 pmRNSHolding(s) in Company
13th Nov 20134:49 pmRNSMonthly Report - September 2013
13th Nov 20134:47 pmRNSNet Asset Value(s)
12th Nov 20135:39 pmRNSHolding(s) in Company
17th Oct 20134:46 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.